Anthony G. Quinn - President & CEO, Director at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Issuer Symbol
SYRE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Anthony G. Quinn since 14 Jan 2025

Holdings reported by Anthony G. Quinn for Spyre Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 550,540 $308,743 $0.5608 16 Mar 2022 Direct
Common Stock 266,295 $149,338 $0.5608 16 Mar 2022 By trusts
Employee Stock Option (right to buy) 350,000 17 Feb 2022 Direct Common Stock

Transactions reported by Anthony G. Quinn for Spyre Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.